-
Innovation Ranking
NewInnovation Ranking – DS Smith Plc
DS Smith Plc (DS Smith) is a provider of paper and packaging solutions. Its product portfolio includes retail and shelf-ready packaging, transit cases, consumer boxes, corrugated packs, point of sale displays and heavy-duty industrial products. It also offers consultancy services on creative design and supply chain audit. The company manufactures recycled papers including corrugated case materials (CCM) and specialty papers for the packaging industry. It carries out cardboard and paper recycling activities such as paper recycling, cardboard recycling, confidential shredding,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-3939 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-3939 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DS-3939 in Solid Tumor Drug Details: DS-3939 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-1594b in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-1594b in Myelodysplastic Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DS-1594b in Myelodysplastic Syndrome Drug Details: DS-1594b is under investigation for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-3939 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-3939 in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DS-3939 in Metastatic Breast Cancer Drug Details: DS-3939 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-3939 in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-3939 in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DS-3939 in Pancreatic Ductal Adenocarcinoma Drug Details: DS-3939 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-3939 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-3939 in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DS-3939 in Metastatic Ovarian Cancer Drug Details: DS-3939 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-3939 in Metastatic Biliary Tract Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-3939 in Metastatic Biliary Tract Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DS-3939 in Metastatic Biliary Tract Cancer Drug Details: DS-3939...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-1594b in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-1594b in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DS-1594b in Relapsed Acute Myeloid Leukemia Drug Details: DS-1594b is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-1594b in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-1594b in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DS-1594b in Refractory Acute Myeloid Leukemia Drug Details: DS-1594b is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-1594b in Chronic Myelomonocytic Leukemia (CMML)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-1594b in Chronic Myelomonocytic Leukemia (CMML) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DS-1594b in Chronic Myelomonocytic Leukemia (CMML) Drug Details: DS-1594b is...